MarketPeel
Insider Trading Intelligence
JG

Jeremy R. Graff

ALLR
SEE REMARKS · ALLARITY THERAPEUTICS, INC. · CIK 0001975028
FILING MIX · LIFETIME84%/16%
BUYS
16
SELLS
3
TOTAL VALUE
$275.5K
COMPANIES
2
ACTIVE SINCE
May 2023
HOLDINGS NOW
403,644
AVG SELL PX
$1.58
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jeremy R. Graff, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+23.27%-1.42%+24.69%+24.69%
14d1+100.00%+14.77%-4.25%+19.02%+19.02%
30d1+0.00%-0.64%-3.02%+2.38%+2.38%
60d1+100.00%+11.58%-1.07%+12.65%+12.65%
90d1+100.00%+73.75%+4.31%+69.44%+69.44%
180d1+100.00%+34.96%+15.38%+19.59%+19.59%
1y1+0.00%-68.01%+26.96%-94.98%-94.98%
2y1+0.00%-92.56%+50.71%-143.27%-143.27%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ALLR · 381,644 shares · as of Jan 28, 2026
095,411190,822286,233381,64420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 3 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
22,00022,000May 9, 2026May 12, 2026View →
ALLR
ALLARITY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
133,333381,644Jan 28, 2026Apr 30, 2026View →
ALLR
ALLARITY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
133,333381,644Jan 7, 2026Jan 16, 2026View →
ALLR
ALLARITY THERAPEUTICS, INC.
SALE
See Remarks
39,494223,430Sep 30, 2025Oct 2, 2025View →
ALLR
ALLARITY THERAPEUTICS, INC.
PURCHASE
See Remarks
39,49439,494Sep 30, 2025Oct 2, 2025View →
ALLR
ALLARITY THERAPEUTICS, INC.
SALE
See Remarks
14,613$1.58$23.1K24,881Sep 30, 2025Oct 2, 2025View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
63,15063,150May 8, 2025May 12, 2025View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
2,0492,049Apr 27, 2025May 7, 2025View →
INAB
IN8BIO, INC.
SALE
2,0490Apr 27, 2025May 7, 2025View →
ALLR
ALLARITY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
144,441262,924Jan 22, 2025Jan 24, 2025View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
47,69747,697Dec 19, 2024Dec 23, 2024View →
ALLR
ALLARITY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
118,483$2.11$250.0K118,483Sep 30, 2024Oct 1, 2024View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
33,65033,650Jun 12, 2024Jun 14, 2024View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
2,0494,549Dec 13, 2023Dec 15, 2023View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
2,0492,049Dec 13, 2023Dec 15, 2023View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
2,0492,049Dec 13, 2023Dec 15, 2023View →
INAB
IN8BIO, INC.
PURCHASE
2,500$0.95$2.4K2,500Sep 13, 2023Sep 15, 2023View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
85,00085,000Jun 15, 2023Jun 16, 2023View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
27,00027,000May 1, 2023May 3, 2023View →
Other insiders · ALLR
Loading peer insiders…
About this filer
CIK 0001975028
ROLE
See Remarks
PRIMARY
ALLR
COMPANIES
2
ACTIVE SINCE
May 2023
MARKETPEEL · /INSIDER/0001975028DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback